PCORnet® 2020: current state, accomplishments, and future directions.

PCORnet® 2020: current state, accomplishments, and future directions.
复制标题

DOI:
10.1016/j.jclinepi.2020.09.036
复制
发表时间:
2021-01
影响因子:
7.2
通讯作者:
Carton TW
Carton TW
中科院分区:
医学2区
文献类型:
--
作者:
Forrest CB;McTigue KM;Hernandez AF;Cohen LW;Cruz H;Haynes K;Kaushal R;Kho AN;Marsolo KA;Nair VP;Platt R;Puro JE;Rothman RL;Shenkman EA;Waitman LR;Williams NA;Carton TW

文献摘要

参考文献

被引文献

相似文献

描述PCORnet,这是一个临床研究网络,用于在全国范围内进行以患者为中心的结局研究。PCORnet的现状和未来方向的描述性研究。我们对PCORnet的9个临床研究网络和2个健康计划研究网络的卫生系统和患者人群进行了横断面分析。在临床研究网络内,目前从337家医院、169,695名医生、3,564个初级保健诊所、338个急诊室和1,024个社区诊所收集电子健康数据。可以从任何这些临床研究中心招募患者进行前瞻性研究。临床研究网络从2009年到2018年至少有一次就诊的8000万患者中积累了数据。从2009年到2019年,PCORnet健康计划研究网络的有效登记人群超过6000万人,平均随访2.63年。PCORnet的基础设施包括来自不同患者队列的临床数据,并有能力快速访问这些患者人群,以进行实用的临床试验,流行病学研究和以患者为中心的罕见疾病研究。
To describe PCORnet, a clinical research network developed for patient-centered outcomes research on a national scale. Descriptive study of the current state and future directions for PCORnet. We conducted cross-sectional analyses of the health systems and patient populations of the 9 Clinical Research Networks and 2 Health Plan Research Networks that are part of PCORnet. Within the Clinical Research Networks, electronic health data are currently collected from 337 hospitals, 169,695 physicians, 3,564 primary care practices, 338 emergency departments, and 1,024 community clinics. Patients can be recruited for prospective studies from any of these clinical sites. The Clinical Research Networks have accumulated data from 80 million patients with at least one visit from 2009 to 2018. The PCORnet Health Plan Research Network population of individuals with a valid enrollment segment from 2009 to 2019 exceeds 60 million individuals, who on average have 2.63 years of follow-up. PCORnet’s infrastructure comprises clinical data from a diverse cohort of patients and has the capacity to rapidly access these patient populations for pragmatic clinical trials, epidemiological research, and patient-centered research on rare diseases.
DOI: 10.1097/acm.0000000000000794
发表时间: 2015-12
期刊: Academic medicine : journal of the Association of American Medical Colleges
影响因子: --
作者:
Joosten YA;Israel TL;Williams NA;Boone LR;Schlundt DG;Mouton CP;Dittus RS;Bernard GR;Wilkins CH
通讯作者: Wilkins CH
PCORI 试点项目中的患者和利益相关者参与:描述和经验教训。
DOI: 10.1007/s11606-015-3450-z
发表时间: 2016-01
影响因子: 5.7
作者:
Forsythe LP;Ellis LE;Edmundson L;Sabharwal R;Rein A;Konopka K;Frank L
通讯作者: Frank L
DOI: 10.1177/1740774519846853
发表时间: 2019-08-01
期刊: CLINICAL TRIALS
影响因子: 2.7
作者:
Ma, Qinli;Chung, Haechung;Haynes, Kevin
通讯作者: Haynes, Kevin
DOI: 10.1177/1740774520902989
发表时间: 2020-02-03
期刊: CLINICAL TRIALS
影响因子: 2.7
作者:
Shi, Qian;Shambhu, Sonali;Haynes, Kevin
通讯作者: Haynes, Kevin
DOI: 10.13063/2327-9214.1213
发表时间: 2016-01-01
期刊: EGEMS (Washington, DC)
影响因子: --
作者:
Davies, Melanie;Erickson, Kyle;Brown, Jeffrey
通讯作者: Brown, Jeffrey